Residency Hardware Tools
Beta Testing
Note: Results are not Guaranteed and May Vary
ABC-IQ Biotechnologies
- Manual New Frontiers of Cannabinol pathic medicine in Mind Science
- Dose Guide
- Data Collection / Scan Tests Comprehensive Assessment Formulating the Global Standard
Research Strain, Dose, Impact
Software Integration
Cannabis and its role in Myelination
Therapeutic Impact Effectiveness
Introduction to Cannabinol pathic Medicine in Mind Science Research
Self Study
Observation Impact
Certificate Overview
🌱 ABC-IQ Level 5: MSL5 Specialization
New Professional Credential.
Doctor of Cannabinol pathic Medicine in Mind Science
Credential: ABC-IQ Level 5 Certificate in Cannabinol-Pathic Medicine Biotechnology Diagnostics Tool
Prompt Engineering
Beta Testing Practice Dispensary Tools
Recommended MCAT study for MD and CBD Competency By Design by Royal College of Physicians and Surgeons
Manual New Frontiers of Cannabinol Pathic Medicine in Mind Science Manual and Dose Guide with Biotechnologies
- Publishing Credentialed professionals in Cannabinolpathic Medicine (D.C.M.M.S.) (Doctor of Cannabinol pathic medicine in mind science)
- Peer-reviewed publications and ISBN-International Standard Book Numbers, authorized curriculum materials
Research Publication: Scientific Studies
Canada Certification Regulation Standards
Delivery Format: Research-Based Fieldwork + Theory-to-Practice Manual + Residency/Field Lab
Observation / Data Collection Survey
📚 Program Description:
Level 5 is a specialization and practicum-based program that bridges research theory to publishing and practical field experience in cannabinol-pathic medicine, biotechnologies, and micro-agriculture systems.
Using ABC-IQ’s Manual: Theory to Practice, students integrate protocols into practice.
Observation survey - Research Protocols as Outlined by Health Canada
Online program certificate validation.
🧪 Skills & Competencies Covered:
- Application of Cannabinol-Pathic Medicine protocols in diagnostics and care
- Setup and management of a biotech dispensary suite
- Use of beta-test diagnostic tools in a practice environment
- Micro-breeding and medical agriculture fundamentals (ranch, greenhouse, indoor)
- Farm-to-gate distillery integration for patient and wellness centers
- Conditional response tracking for treatment effectiveness
- Market operations: retail interface, diagnostics, patient education
🧠 Research Components:
- Manual: Research Theory to Practice (core text)
- Collection of conditional response data on patients and test users
- Comparison of plant, synthetic, placebo and impact across case studies
- Submission of Impact Effectiveness Portfolio
🎯 Learning Objectives:
Upon completion of Level 5, learners will: Beta Testing
- Research operations of a dispensary suite aligned with diagnostic and regulatory standards
- Cultivate, monitor, and manage plant growth cycles in medical cannabis contexts
- Use micro-breeding tools and medical agriculture strategies for custom outcomes
- Analyze and present therapeutic impact data through conditional research
📁 Assessment & Research Residency Requirements:
- Completion of the Manual: Theory to Practice with field application
- Registered completion of Field Residency.
- Submission of Research Portfolio:
- Testing Specialization
- Certified under MSL5
🧩 Key Program Themes:
Focus Area Description Cannabinol-Pathic Medicine Therapeutic applications of plant medicine in diagnostics Medical Agriculture Indoor and micro-breeding practices for custom strains
Biotech Retail Tools Operating diagnostics tools and tracking patient feedback Distillery Integration Farm gate model for oils, tinctures, and nano-dosages
Regulatory Standards for Operations
👨🔬 Career Pathways After Level 5:
- Specialist in Cannabinol-Pathic Medicine
- Research Assistant or Field Data Analyst
- Biotech Retail Suite Operator
- Health Policy Advisor (Cannabis Industry, Regulatory Advocacy)
🌿 Capstone Project:
Field Study: Conditional Response to Cannabinol vs Placebo Across 100 Case Studies - Residency Scan Tools + 2 Years with Field Hours of Practice for Designation
Biotechnologies tool sold separately.
Approximate tool cost $10 000 CAD.
Program and Courses Medical College: Research to Pactise
MD Designation Research to Practise
Preparing for certification. What to expect.
CBD Competency By Design. Medical College Admissions Test MD .
Manual New Frontiers of Cannabinol pathic medicine in mind science.
Dose, strain, impact effectiveness.
Biotechnology Diagnostics Tool+ Prompt Engeneering
🎓 ABC-IQ University College Residency Program Leading the Future of Cannabinol Pathic Medicine and Retail Science
Program Overview ABC-IQ’s Residency Program offers a groundbreaking educational pathway that merges cannabinoid science with retail and dispensary operations. Designed for aspiring physicians and cannabinoid specialists, the program prepares candidates for Royal College of Physicians and Surgeons certification while equipping them with practical skills in dispensary research, product fulfillment, and therapeutic innovation.
Core Components
- 🧠 Mind Science Manual: A foundational guide to the neurocognitive and therapeutic dimensions of Cannabinol Pathic Medicine
- 🌿 Dispensary Research Labs: Hands-on exploration of cannabinoid formulations, dosing protocols, and consumer behavior analytics
- 📦 Retail Fulfillment Training: Inventory systems, compliance, patient education, and product lifecycle management
- 🔬 Cannabinoid Therapeutics Modules: Covering pharmacology, safety standards, legal frameworks, and ethics
- 🧪 Innovation Labs: Development of plant-based therapies and translational research initiatives
- 🧭 Simulation-Based Learning: ABC-IQ’s proprietary diagnostic platforms and retail scenario simulations
Recommended Courses & Tools
- 📘 MCAT Enrollment & Analytics: Strengthening foundational science and entry readiness
- 🧠 ABC-IQ Retail Exams: Simulated assessments aligned with government retail dispensary standards
- Tool use, Prompt Engineering
- 📚 Royal College Prep Modules: Structured study for certification in cannabinoid-focused medicine
- 🧰 Study Tools: Interactive diagnostics, peer-reviewed literature.
- ABC-IQ Research Tool Kit
Mind Science applying the law of attraction to the multiple intelligences.
Understanding Time, E=ME2, the brain and learning styles.
PBL in Medicine
Systematic problem solving through creative meditation. Processes of application.
Medical Growth
Producing medical grade cannabis and bi products for health. Medical agriculture. Understanding the science of the plant.
Understanding the Aura
Review of meridians, eastern philosophy and western tradition, aura organ analysis.
Publishing
Scientific data student choice. Cannabis, plant centered.
Therapeutic Impact Effectiveness THC Cannabis, Marijuana, CBD
Competency by design, CBD, vs THC.
Cannabinol, tetrahydrocannabinol, medical impact.
- Post-Traumatic Stress Disorder (PTSD): PTSD is a mental health condition triggered by a terrifying event, either experiencing it or witnessing it. Symptoms may include flashbacks, nightmares, severe anxiety, and uncontrollable thoughts about the event1.
- Complex Post-Traumatic Stress Disorder (C-PTSD): C-PTSD can result from experiencing chronic trauma, such as prolonged child abuse or domestic violence. It’s closely related to PTSD and involves stress responses like anxiety, flashbacks or nightmares, avoidance of situations related to the traumatic event, heightened emotional responses, and persistent difficulties in sustaining relationships
- CBD / THC Pharmacology Myelination Cannabidiol and Other Cannabinoids in Demyelinating Diseases
Register Form
Dispensary Residency In Development Pilot Beta Testing
Mobile suite of tools.
Recommended student take MCAT, CBD, + ABC-IQ Manuals of study. for Doctoral MD publishing.
Review Plant Synthetic
🌿 What's the Difference?
Let’s define the main terms:
1. Hemp
- A variety of the Cannabis sativa plant.
- Grown legally for fiber, food (hemp hearts), clothing, biofuel, and CBD.
- Contains <0.3% THC, so non-psychoactive (you won’t get “high”).
- Rich in CBD, but not used recreationally.
- Used in industrial and nutritional products.
2. CBD (Cannabidiol)
- A non-psychoactive cannabinoid from cannabis (also found in hemp).
- Known for anti-inflammatory, anti-anxiety, anti-seizure properties.
- Used in epilepsy (e.g., Epidiolex), PTSD, arthritis, sleep disorders.
- Won’t make you feel “high.” Often used for calming, pain relief, and neuroprotection.
3. THC (Tetrahydrocannabinol)
- The main psychoactive compound in cannabis.
- Causes the “high”, but also has powerful medicinal effects:
- Pain relief
- Anti-nausea (especially for chemotherapy)
- Appetite stimulation
- Muscle spasm relief (e.g., MS, spinal injuries)
- PTSD and trauma processing
- Medicine is in the THC, especially in plant combinations with CBD for balance.
THC is not just recreational—it's often the most powerful therapeutic agent in severe cases (like cancer, end-of-life care, PTSD, or trauma-induced pain).
🧬 Is the Medicine in the THC?
Yes. Here’s how medical science sees it:
- THC interacts with CB1 receptors in the brain & central nervous system.
- These receptors regulate pain, emotion, memory, and appetite.
- The Endocannabinoid System (ECS)—found in all humans—relies on this for balance (homeostasis).
- The human body naturally makes cannabinoids (like anandamide, the “bliss molecule”).
When things like trauma, illness, or stress disrupt your ECS, plant-based cannabinoids (like THC) can restore balance.
📜 Brief History (And Why It’s Confusing)
Year / EraWhat Happened2700 BCE (China)Cannabis used as medicine for pain, seizures, menstruation1800s (Europe)Prescribed widely for headaches, rheumatism, depression1920s–30s (USA)Politicized and racialized as “Marijuana” → criminalized (racism, fear)1961 (UN Treaty)Cannabis classified as a narcotic (Single Convention on Narcotic Drugs)1996 (California)Legal medical marijuana returns → cancer/AIDS patients2000s–2020sCBD legalized, THC reintroduced with scientific support
The criminalization of cannabis wasn’t based on science—it was rooted in racism, xenophobia, and corporate lobbying.
🧠 Is Something “Wrong” With You?
Let’s pause here:
No. Nothing is wrong with you.
If you:
- Feel relief with THC or CBD,
- Are using it to sleep, process trauma, manage anxiety,
- Have pain that traditional medicine doesn’t address,
- Or just feel better and more yourself with cannabis...
That’s your body’s intelligence communicating with the medicine it needs.
Just because society labeled it “bad” doesn’t mean your biology is wrong. You’re tapping into a healing process.
🧪 What’s Treatment?
Cannabis is now medically approved for:
- Chronic pain (esp. nerve pain)
- Epilepsy
- Chemotherapy-induced nausea
- MS spasticity
- PTSD
- Anxiety
- Appetite loss / wasting
- Parkinson’s, Alzheimer’s (supportive)
- End-of-life care
- Sleep disorders
- Inflammation and autoimmune conditions
Each person’s endocannabinoid system is unique. That’s why some people need more THC, some just CBD, and others both.
🌈 Conclusion
- Hemp is non-psychoactive, used for food/fiber.
- CBD calms and heals, THC relieves and empowers.
- The medicine is in the THC, but it must be personalized and respected.
Doctoral Program Currently In Development Cannabinol Pathic Medicine in Mind Science Residency
🧠 Overview of Key Points
The document outlines ABC-IQ’s pioneering framework for Cannabinolpathic Medicine in Mind Science™, integrating botanical intelligence, neuroscience, diagnostics, and emotional intelligence. It introduces the Doctor of Cannabinolpathic Medicine in Mind Science (D.C.M.M.S.) credential and a Level 5 curriculum model that merges ancient plant wisdom with modern therapeutic science. Key components include:
- 🌿 Cannabinol (CBN) as a therapeutic agent: non-psychoactive, anti-inflammatory, sedative, and neuroprotective
- 🧬 Diagnostic tools: Biopulsar Reflexograph, Veritas™ Sensor, Kirlian photography, aura diagnostics, and TIME™ mental mapping
- 🌈 Emotional and spiritual intelligence: integration of guided meditations, plant rituals, and vibrational healing
- 🧪 Terpene and cannabinoid profiling: for personalized medicine and synergistic therapeutic effects
- 🍇 Edible medicinals: wine tannins, grape phytochemicals, and culinary infusions as therapeutic formats
- 🧘♀️ Holistic health: emphasis on neuroplasticity, trauma integration, and mood mapping
- 🌍 Legal and ethical frameworks: global advocacy, safety protocols, and institutional oversight
🌟 Vision Statement
To revolutionize global health and education by advancing Cannabinolpathic Medicine in Mind Science™ as a lawful, ethical, and evidence-based discipline that empowers emotional intelligence, neurobiological healing, and botanical diagnostics.
🎯 Mission Statement
ABC-IQ’s mission is to lead interdisciplinary research and education in Cannabinolpathic Medicine by integrating plant pharmacology, diagnostic innovation, and emotional intelligence into personalized therapeutic models. We aim to credential professionals, destigmatize plant-based healing, and foster global collaboration for systemic transformation.
📚 Research Mandate Overview
ABC-IQ’s research mandate is to explore, validate, and disseminate knowledge on the therapeutic applications of cannabinol (CBN), terpenes, and phytochemicals through integrative diagnostics, emotional intelligence frameworks, and personalized medicine. This includes curriculum development, clinical trials, and product innovation.
🧭 Research Objectives
- Investigate the pharmacological effects of CBN and terpene profiles on cognitive, emotional, and physiological health
- Validate diagnostic tools (e.g., Biopulsar, Veritas™, Kirlian photography) for mood mapping and neurobalance
- Develop therapeutic applications including elixirs, infusions, and digital mood diagnostics
- Integrate emotional intelligence and behavioral therapy with cannabinoid-based treatments
- Promote ethical cultivation, legal advocacy, and cultural respect for plant medicine traditions
🎓 Expected Outcomes
- Credentialed professionals in Cannabinolpathic Medicine (D.C.M.M.S.)
- Peer-reviewed publications and ISBN-authorized curriculum materials
- Validated diagnostic protocols for emotional and neurobiological tracking
- Therapeutic product lines (e.g., cannabinoid-infused culinary treatments)
- Policy contributions and global recognition of Cannabinolpathic Medicine as a formal discipline
(2025 Program Statement)
Research Empircal Data
Cannabis and Myelination
1. Cannabis and Myelination
- Zamberletti, E., Gabaglio, M., & Rubino, T. (2014). The endocannabinoid system and schizophrenia: Integration of preclinical and clinical findings. Current Pharmaceutical Design, 20(13), 2102–2113. https://doi.org/10.2174/13816128113199990367
- Kim, H., & Thayer, S. A. (2001). Cannabinoids inhibit the proliferation of neural progenitor cells in the developing rat hippocampus. Journal of Neuroscience, 21(23), 7931–7940. https://doi.org/10.1523/JNEUROSCI.21-23-07931.2001
2. THC, CBD, and the Endocannabinoid System
- Pertwee, R. G. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol, and Δ9-tetrahydrocannabivarin. British Journal of Pharmacology, 153(2), 199–215. https://doi.org/10.1038/sj.bjp.0707442
- Mechoulam, R., & Parker, L. A. (2013). The endocannabinoid system and the brain. Annual Review of Psychology, 64, 21–47. https://doi.org/10.1146/annurev-psych-113011-143739
- Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012). Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philosophical Transactions of the Royal Society B: Biological Sciences, 367(1607), 3364–3378. https://doi.org/10.1098/rstb.2011.0389
3. Cannabis as Medicine / Therapeutic Effects
- Whiting, P. F., Wolff, R. F., Deshpande, S., et al. (2015). Cannabinoids for medical use: A systematic review and meta-analysis. JAMA, 313(24), 2456–2473. https://doi.org/10.1001/jama.2015.6358
- Hill, K. P. (2015). Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review. JAMA, 313(24), 2474–2483. https://doi.org/10.1001/jama.2015.6199
- Lu, H.-C., & Mackie, K. (2016). An introduction to the endogenous cannabinoid system. Biological Psychiatry, 79(7), 516–525. https://doi.org/10.1016/j.biopsych.2015.07.028
4. Myelination and Cannabinoids
- Molina-Holgado, F., & Guaza, C. (2001). Cannabinoids and neuroprotection in CNS inflammation. CNS & Neurological Disorders-Drug Targets, 1(3), 249–262. https://doi.org/10.2174/1871527013349375
- Beltramo, M., & Piomelli, D. (2000). Endocannabinoids and neuroprotection in ischemia. Pharmacology & Therapeutics, 88(1), 77–89. https://doi.org/10.1016/S0163-7258(00)00021-0
Empirical Research Articles – Cannabis, C-PTSD, Neuropathic Pain, Trauma
Elms, L., Shannon, S., Hughes, S., & Lewis, N. (2019). Cannabidiol in the treatment of post-traumatic stress disorder: A case series. Journal of Alternative and Complementary Medicine, 25(4), 392–397. https://doi.org/10.1089/acm.2018.0437
Greer, G. R., Grob, C. S., & Halberstadt, A. L. (2014). PTSD symptom reports of patients evaluated for the safety and efficacy of medical cannabis. Journal of Psychoactive Drugs, 46(1), 73–77. https://doi.org/10.1080/02791072.2013.873918
Passie, T., Emrich, H. M., Karst, M., & Brandt, S. D. (2002). Mitigation of post-traumatic stress symptoms by cannabis resin: A review of clinical and neurobiological evidence. Pharmacopsychiatry, 35(5), 146–152. https://doi.org/10.1055/s-2002-33184
Whiting, P. F., Wolff, R. F., Deshpande, S., et al. (2015). Cannabinoids for medical use: A systematic review and meta-analysis. JAMA, 313(24), 2456–2473. https://doi.org/10.1001/jama.2015.6358
Hill, K. P. (2015). Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review. JAMA, 313(24), 2474–2483. https://doi.org/10.1001/jama.2015.6199
Reiman, A. (2009). Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients. Addiction Research & Theory, 17(5), 501–510. https://doi.org/10.1080/16066350802419700
Naftali, T., Mechulam, R., Marii, A., et al. (2014). Cannabis for chronic visceral pain in inflammatory bowel disease: A prospective placebo-controlled study. Clinical Gastroenterology and Hepatology, 12(9), 1537–1542. https://doi.org/10.1016/j.cgh.2014.03.033
Batalla, A., Bhattacharyya, S., Yücel, M., et al. (2013). Structural and functional imaging studies in chronic cannabis users: A systematic review of adolescent and adult findings. PLOS ONE, 8(2), e55821. https://doi.org/10.1371/journal.pone.0055821
Hurd, Y. L., Yoon, M., Manini, A. F., et al. (2015). Early phase in the development of cannabidiol as a treatment for addiction: Opioid relapse, cannabis and cocaine. Neurotherapeutics, 12(4), 807–815. https://doi.org/10.1007/s13311-015-0373-7
Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015). Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics, 12(4), 825–836. https://doi.org/10.1007/s13311-015-0387-1
Medical impact of cannabis,
Whiting, P. F., Wolff, R. F., Deshpande, S., et al. (2015). Cannabinoids for medical use: A systematic review and meta-analysis. JAMA, 313(24), 2456–2473. https://doi.org/10.1001/jama.2015.6358
Hill, K. P. (2015). Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review. JAMA, 313(24), 2474–2483. https://doi.org/10.1001/jama.2015.6199
Mechoulam, R., & Parker, L. A. (2013). The endocannabinoid system and the brain. Annual Review of Psychology, 64, 21–47. https://doi.org/10.1146/annurev-psych-113011-143739
Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015). Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics, 12(4), 825–836. https://doi.org/10.1007/s13311-015-0387-1
Russo, E. B. (2008). Cannabinoids in the management of difficult to treat pain. Therapeutics and Clinical Risk Management, 4(1), 245–259. https://doi.org/10.2147/TCRM.S1928
Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012). Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philosophical Transactions of the Royal Society B: Biological Sciences, 367(1607), 3364–3378. https://doi.org/10.1098/rstb.2011.0389
Pertwee, R. G. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol, and Δ9-tetrahydrocannabivarin. British Journal of Pharmacology, 153(2), 199–215. https://doi.org/10.1038/sj.bjp.0707442
Hill, K. P., Palastro, M. D., Johnson, B., & Ditre, J. W. (2017). Cannabinoids and pain: New insights from old molecules. The Clinical Journal of Pain, 33(9), 891–897. https://doi.org/10.1097/AJP.0000000000000451
Whiting, P. F., Deshpande, S., & Benninger, M. S. (2018). Systematic review of the therapeutic efficacy of cannabis in multiple medical conditions. European Journal of Internal Medicine, 49, 1–9. https://doi.org/10.1016/j.ejim.2018.01.010
Abrams, D. I. (2018). The therapeutic effects of cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering, and Medicine report. Journal of the American Medical Association, 320(23), 2351–2352. https://doi.org/10.1001/jama.2018.19766
ABC-IQ Dispensary Biotechnologies
Medical & Retail Supply Chain Support Tools
Manual Designation Review Subject Guide
Levels 1 - 7 In Publication (2025 / 2026)
New Frontiers of Cannabinol Pathic Medicine in Mind Science Guide
FAQs
-
Yes, ABC-IQ courses include text books in most courses., Courses in include e-book, chapter books and or interactive technologies to support learners.
-
At this time, sponsorship is not required, as all programs are online with student learning housed in a central space with online content with all business retail operations managed locally irrespective of climate
ABC-IQ empowers equal opportunities through technology as a service and online operations support.
-
All full time, part time students and users of ABC-IQ are asked to pay the enrollment fee of $200. This non refundable fee supports content delivery and on demand channel workforce activities providing users lifetime access to the ABC-IQ Channel as registered students of ABC-IQ.
-
ABC-IQ programs are designed for learn at your own pace, while streamlined to a traditional academic year for 6 months online learning and 6 months applied science learning. Hours of practice vs credit hours vary per program for a combined learning credit.
Prices and levels for certifications are varied and increase per year of study. One login link provides year long program of study.
Micros courses and theme electives are sold separately to expand further study.
-
24 Weeks Online Study
24 Weeks Offline Self Care Implementation
48 Week Program
🧪 ABC-IQ Field Lab: One-Year Credit Hour Structure
📍 Duration: 12 Months (48 Weeks)
Assuming:
- 15 hours/week of active engagement (hands-on practice, guided research, journaling, guided materials and applied study)
- Total Hours: 15 hrs/week × 48 weeks = 720 hours
🎓 Credit Hour Conversion
Using the Carnegie Unit:
- 1 credit hour = 45 total hours (instruction + study)
- 720 hours ÷ 45 = 16 credit hours
- Total Credit Hours: 36
- Work Experience: 480 hours Self-Practice Integration: 180 hours Daily Self-Care Base: ~427 hours
-
Submission for research is inside the ABC-IQ portal however, to prepare for research thesis for professional publishing on ABC-IQ please review short course.